Alle Storys
Folgen
Keine Story von Semperit AG Holding mehr verpassen.

Semperit AG Holding

EANS-News: Semperit AG Holding
Sempermed Builds New Glove Factory in Malaysia - largest investment ever made by Semperit (with photo)

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------

Company Information/Investment

The Semperit Group is expanding production capacity at the Kamunting, Malaysia
site of its Sempermed segment. A total of about EUR 50 million (MYR 220 million)
will be invested in the period 2014 - 2016 to build a new glove factory. This is
the largest investment in capacity increase ever made in the history of
Semperit. 
Construction of the new facility will take place on the premises of the
Kamunting plant, where Semperit has been operating six production facilities for
medical and protective gloves since its acquisition of Latexx Partners Berhad in
2012. The first gloves are expected to leave the production lines starting in
the middle of 2015, with the entire project scheduled for completion at the end
of 2016. 

Next step in the growth strategy 
"The integration of Latexx Partners into the Sempermed segment was successfully
concluded last year. The capacity expansion drive at Latexx Partners will enable
us to strengthen our position on the global glove market and move a decisive
step closer towards achieving our designated growth targets", says Thomas
Fahnemann, Chief Executive Officer of Semperit AG Holding. "We can only reach
this goal by offering competitive production costs. For this reason, the new
facility will deploy state-of-the-art technologies as the basis for a high level
of automation and the optimal use of natural resources. It will be one of the
world's most efficient manufacturing plants for nitrile gloves", CEO Fahnemann
continues.

Production speed will be significantly increased compared to the performance of
existing factories. The new facility will also boast 50% lower gas consumption,
and electricity needs will be about 20% less than for conventional glove
manufacturing technologies.  

The new investments will lay the groundwork for Sempermed to continue its
expansion path on the growth market for examination gloves featuring an increase
in demand of about 5-7% annually. 


About Semperit 
The publicly listed company Semperit AG Holding is an internationally-oriented
group that develops, produces, and sells in more than 100 countries highly
specialised rubber and plastic products for the medical and industrial sectors:
examination and surgical gloves, hydraulic and industrial hoses, conveyor belts,
escalator handrails, construction profiles, cable car rings, and products for
railway superstructures. The headquarters of this long-standing Austrian
company, which was founded in 1824, are located in Vienna, and the global R & D
centre is in Wimpassing, Lower Austria. The Semperit Group employs about 10,800
people worldwide, including more than 8,000 in Asia and more than 700 in Austria
(Vienna and production site in Wimpassing, Lower Austria). The Group has 22
manufacturing facilities worldwide and numerous sales offices in Europe, Asia,
and America. In 2013 the Group generated sales of EUR 906 million and an EBITDA
of EUR 133 million.


About Sempermed 
Sempermed is the largest segment in the Semperit Group, and ranks among the
world's leading manufacturers of medical and industrial gloves. The research
centre of Sempermed located in Wimpassing, Lower Austria continuously develops
and tests new products in cooperation with users and experts. Sempermed has been
producing gloves of the highest quality for more than 90 years, and as the
world's technology leader sets standards in quality and innovation. Sempermed
guarantees optimal safety and reliability thanks to state-of-the-art
manufacturing technologies, the highest attainable production hygiene and the
strictest quality controls. In 2013, the Segment Sempermed generated revenue of
EUR 435 million (approx. 48% of Group revenue) and an EBITDA of EUR 59 million.
Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/lM71utUe

Further inquiry note:
Martina Büchele 		
Head of Group Communications
Tel.: +43 676 8715 8621		
 
martina.buechele@semperitgroup.com
www.semperitgroup.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


Pictures with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/lM71utUe
;


company:     Semperit AG Holding
             Modecenterstrasse 22
             A-1030 Wien
phone:       +43 1 79 777-210
FAX:         +43 1 79 777-602
mail:         investor@semperitgroup.com
WWW:      www.semperitgroup.com
sector:      Synthetics & Plastics
ISIN:        AT0000785555
indexes:     WBI, ATX Prime, ViDX, Prime Market, ATX Global Players
stockmarkets: official market: Wien 
language:   English

Original-Content von: Semperit AG Holding, übermittelt durch news aktuell

Weitere Storys: Semperit AG Holding
Weitere Storys: Semperit AG Holding